Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Biomechanics (Bristol, Avon)|May 18, 2025
High-speed x-ray characterizes fracture incidence and bone-implant motion during a fall from standingEmily K Bliven, Pierre Guy, Alexander Baker, et al.
Advances in Therapy|June 26, 2023
Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United StatesJesse A Sussell, David J Press, Svenn A Hansen, et al.
Medical Engineering & Physics|November 1, 2025
A user-defined element for simulating hydrogel injection into trabecular bone: Numerical simulations and experimental validationGeorgios F Samaras, Vincent Dischl, Anita Fung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II StudyNancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
NPJ Breast Cancer|November 18, 2023
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy dataNancy U Lin, Priya Kumthekar, Solmaz Sahebjam, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 2, 2024
How accurately do finite element models predict the fall impact response of ex vivo specimens augmented by prophylactic intramedullary nailing?Emily K Bliven, Anita Fung, Alexander Baker, et al.
Clinical Biomechanics (Bristol, Avon)|November 27, 2025
Dual-energy X-ray absorptiometry based biofidelic finite element models for simulating falls to the hip: Impact of trochanteric soft tissue thickness on fracture riskDheeraj Jha, Anitha D Praveen, Alexander Baker, et al.
JCO Oncology Practice|July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Pageof 2